BMS 6078 (Metaglip 5 mg / 500 mg)

Generic Name: glipizide/metformin

Pill imprint BMS 6078 has been identified as Metaglip 5 mg / 500 mg.

Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 5 mg / 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Metaglip

Generic Name:

glipizide/metformin

Imprint:

BMS 6078

Strength:

5 mg / 500 mg

Color:

Pink

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Antidiabetic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Bristol-Myers Squibb

National Drug Code (NDC):

00087-6078

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.